Literature DB >> 26517482

Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study.

Omar Sald Elmi1, Habsah Hasan, Sarimah Abdullah, Mat Zuki Mat Jeab, Zilfalil Bin Alwi, Nyi Nyi Naing.   

Abstract

INTRODUCTION: Multidrug-resistant tuberculosis (MDR-TB) has emerged as a major clinical public health threat and challenges the national TB control program in Malaysia. Data that elaborates on the risk factors associated with the development of MDR-TB is highly limited in this country. This study was aimed to determine the risk factors associated with the development of MDR-TB patients in peninsular Malaysia.
METHODOLOGY: This was a case control study; the data were collected from medical records of all the registered MDR-TB patients at five referral TB hospitals in peninsular Malaysia from January 2010 to April 2014. The 105 cases were all confirmed by a positive sputum culture of Mycobacterium tuberculosis for MDR-TB and extensively drug-resistant (XDR)-TB. As a comparison, a total of 209 non-MDR-TB cases were randomly selected as controls.
RESULTS: A total of 105 MDR-TB and 209 non MDR-TB patients were studied. The risk factors associated with MDR-TB within the multivariate analysis were previous tuberculosis treatment, HIV infection, being an immigrant, and high load of positive for acid-fast bacillus (AFB) smear.
CONCLUSIONS: The findings of this study revealed that patients who had received previous treatment for tuberculosis, were infected with HIV, were immigrants, and had a high burden of positive testing for AFB smear were more likely to have MDR-TB. An enhanced understanding of the risk factors associated with MDR-TB strains is imperative in the development of a national policy for public health interventions.

Entities:  

Mesh:

Year:  2015        PMID: 26517482     DOI: 10.3855/jidc.6162

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  8 in total

1.  Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis.

Authors:  Ying Xi; Wei Zhang; Rui-Jun Qiao; Jun Tang
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

2.  Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis (MDR- TB) Compared with Non-MDR-TB Infections in Peninsular Malaysia.

Authors:  Omar Salad Elmi; Habsah Hasan; Sarimah Abdullah; Mat Zuki Mat Jeab; Zilfalil Ba; Nyi Nyi Naing
Journal:  Malays J Med Sci       Date:  2016-06-30

3.  Determinants of Drug-Resistant Tuberculosis in Southern Ethiopia: A Case-Control Study.

Authors:  Daniel Biru; Endrias Markos Woldesemayat
Journal:  Infect Drug Resist       Date:  2020-06-16       Impact factor: 4.003

4.  HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis.

Authors:  Zeeba Zahra Sultana; Farhana Ul Hoque; Joseph Beyene; Md Akhlak-Ul-Islam; Md Hasinur Rahman Khan; Shakil Ahmed; Delwer Hossain Hawlader; Ahmed Hossain
Journal:  BMC Infect Dis       Date:  2021-01-11       Impact factor: 3.090

Review 5.  Developing an evidence assessment framework and appraising the academic literature on migrant health in Malaysia: a scoping review.

Authors:  Allard Willem de Smalen; Zhie X Chan; Claudia Abreu Lopes; Michaella Vanore; Tharani Loganathan; Nicola S Pocock
Journal:  BMJ Open       Date:  2021-01-18       Impact factor: 2.692

6.  Factors Associated with Multi-Drug Resistant Tuberculosis among TB Patients in Selected Treatment Centers of Amhara Region: A Case-Control Study.

Authors:  Getahun Yeshiwas Ambaye; Gebiyaw Wudie Tsegaye
Journal:  Ethiop J Health Sci       Date:  2021-01

7.  Association of Immune Factors with Drug-Resistant Tuberculosis: A Case-Control Study.

Authors:  En-Tao Sun; Dan Xia; Ben-He Li; Jun Ma; Yuan-Yuan Dong; Shu-Shu Ding; Bai-Feng Chen; Yu-Feng Wen
Journal:  Med Sci Monit       Date:  2017-11-09

8.  Profile of drug-resistant tuberculosis in Western Maharashtra.

Authors:  Sudhakar W More; Malangori Abdulgani Parande; Sanjeev W Kamble; Manjunath S Kamble
Journal:  J Family Med Prim Care       Date:  2017 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.